Pharmaceutical Technology Europe
The author lists five key areas to consider when selecting a CDMO to develop highly potent formulations.
Robert Harris
Advertisement
Articles by Robert Harris
The determination of topical bioequivalence requires a multi-faceted approach, tailored specifically to the generic-drug formulation.
Advertisement
Latest Updated Articles
Demonstrating Therapeutic Equivalence for Generic Topical ProductsNovember 2nd 2015
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5